Overview

Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed

Status:
Completed

Trial end date:
2004-01-01

Target enrollment:

Participant gender:

Summary

A study to look at the rates of remission (non re-appearance of erosive esomeprazole) when treated with esomeprazole or lansoprazole; in patients in with erosive esomeprazole (EE) that is in remission (i.e. previously healed EE).

Phase:

Phase 4

Details

Lead Sponsor:

AstraZeneca

Treatments:

Dexlansoprazole
Esomeprazole
Lansoprazole